Thursday, March 28, 2024
spot_img

DGCI panel approve Covovax EUA for 7-11 age group: Source

Date:

Share post:

spot_img
spot_img

New Delhi, June 25:  Drugs Controller General of (DCGI) India on Friday recommended Emergency Use Authorisation (EUA) for Serum Institute of India’s Covovax vaccine for children aged 7-11, a source on Friday.

“The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years,” said the source.

The expert panel recommendation has been sent to the DCGI for final approval.

However, DGCI will review the recommendation before nodding for final approval. The expert panel in its last meeting in April had sought more information from Serum Institute over the application, as per the source.

India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, and in the 12-17 age group with certain conditions on March 9.

IANS

spot_img
spot_img

Related articles

Ukrainian FM arrives in India to build on talks between PM Modi, Volodymyr Zelenskyy

New Delhi, March 28:  Ukrainian Foreign Minister Dmytro Kuleba arrived in New Delhi on Thursday to reinvigorate bilateral...

Trinamool, BJP exchange barbs over ‘white paper’ on MGNREGA, PMAY

Kolkata, March 28:  The ruling Trinamool Congress and the opposition BJP in West Bengal got engaged in a...

Political conspiracy, claims Kejriwal while being taken to Rouse Avenue Court

New Delhi, March 28:  Delhi Chief Minister, Arvind Kejriwal, while being taken to the Rouse Avenue Court on...

Rapid Response Units trained to mitigate HEC in eastern Assam

  Guwahati, March  28: Member volunteers  of  Rapid Response Units (RRU) operating in various human-elephant conflict (HEC) affected areas...